Online Program Home
My Program

Abstract Details

Activity Number: 286 - Quantitative Methods for Decision-Making in Drug Development
Type: Topic Contributed
Date/Time: Tuesday, July 31, 2018 : 8:30 AM to 10:20 AM
Sponsor: Biopharmaceutical Section
Abstract #328951
Title: Data-Driven Biomarker Evaluation in Adaptive Designs Using SIDES
Author(s): Ilya Lipkovich* and Alex Dmitrienko
Companies: IQVIA and Mediana Inc
Keywords: Biomarker-driven design; subgroup identification

We consider a seamless 2 stage design (e.g. Phase 2-3 oncology trial) with a possibility of selecting a biomarker-positive subpopulation based on the results of the first stage. The most promising predictive biomarker (and an optimal cut-off) is identified using the SIDES methodology (Lipkovich et al, 2011 and Lipkovich and Dmitrienko, 2014). Based on predictive power evaluated after the first stage, a decision is made whether to terminate the trial for futility, continue the trial without any changes in the overall patient population, adjust the sample size (target number of events) in the same population, or focus on a subset of the overall population based on the selected biomarker (biomarker -positive subpopulation), possibly in combination with testing the overall effect via an appropriate multiple testing procedure. Our methodology incorporates proper adjustment for subgroup search for the case of selecting a cut-off for a single biomarker. We present the results of a simulation study that evaluates key operating characteristics of this design under different scenarios.

Authors who are presenting talks have a * after their name.

Back to the full JSM 2018 program